Regulation of dendritic cell function by tumour necrosis factor-α antagonists in rheumatoid arthritis
Anti-tumour necrosis factor-a (TNF-a) therapy is an effective treatment for Rheumatoid Arthritis (RA), in part by enhancing immune regulation. It was hypothesised that these immunomodulatory activities were mediated via effects of TNF-a blockade on dendritic cells (DC). Therefore, the effect of this...
Main Author: | Baldwin, Helen Mary |
---|---|
Published: |
University of Newcastle Upon Tyne
2009
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.501279 |
Similar Items
-
Optimal management of patients with resistant rheumatoid arthritis
by: Bingham, Sarah Jane
Published: (2006) -
Anabolic and anticatabolic interventions for the treatment of cachexia in rheumatoid arthritis patients
by: Marcora, Samuele Maria
Published: (2004) -
Use of novel prognostic tools, outcome measures and therapeutic strategies in early rheumatoid arthritis
by: Bejarano, Victoria
Published: (2011) -
Mechanisms & management of tumour necrosis factor-blockade non-response in patients with rheumatoid arthritis
by: Buch, Maya Hema
Published: (2007) -
The regulation of dendritic cell maturation and survival by tumour necrosis factor receptors 1 and 2
by: Maney, Nicola Jayne
Published: (2014)